Gilead Sciences Intends to Raise Prices of HIV Meds in State AIDS Programs
Gilead Sciences Announces Upcoming Price Adjustments Gilead Sciences has revealed its strategy to implement price increases across a range of
Continue ReadingJune 12, 2026
Gilead Sciences Announces Upcoming Price Adjustments Gilead Sciences has revealed its strategy to implement price increases across a range of
Continue ReadingPakistan’s Push for Local Vaccine Production Gains Momentum A Strategic Shift in National Health Policy Pakistan is taking decisive steps
Continue ReadingMedicine Prices Are Climbing Fast—Here’s What You Need to Know A Growing Concern for Patients Across Pakistan: In recent months,
Continue ReadingPakistan Aims for Vaccine Independence Amid Rising Import Costs Pakistan is taking significant steps towards achieving self-reliance in vaccine production.
Continue ReadingPakistan’s Pharmaceutical Industry Faces WHO Prequalification Gap Pakistan, a significant player in regional pharmaceutical manufacturing, lags in the number of
Continue ReadingUS Government Terminates $590 Million Contract with Moderna The US government, under the Trump administration, has officially canceled a significant
Continue ReadingOtsuka Pakistan Limited, a prominent player in the pharmaceutical industry, has announced a temporary shutdown of its production plant in
Continue Readingin recent years, the deregulation of non-essential medicines has played a significant role in boosting the pharmaceutical industry. This move
Continue ReadingA severe shortage of essential and lifesaving medicines has swept across Pakistan, endangering patients who depend on these critical drugs.
Continue ReadingNational Pharmaceutical Alliance Dominates PPMA Elections for 2024-26 Under the guidance and leadership of prominent figures including Mian Asad Shuja-ur-Rehman
Continue Reading